Efficacy Study of an Audio Device Outside Incubator Allowing Broadcasting Maternal Voice on Stability in Preterm Infants
Primary Purpose
Premature Infant
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
maternal voice intervention
Sponsored by
About this trial
This is an interventional other trial for Premature Infant focused on measuring premature infant
Eligibility Criteria
Inclusion Criteria:
- Preterm infants at 28-36 gestational age
- Within 10 days in NICU after delivery
Exclusion Criteria:
- Has a known chromosomal or congenital abnormality
- Major congenital infection
- Brain lesions diagnosed prenatally, or neonatal asphyxia at birth.
- Toxic use by the mother during pregnancy
- Intraventricular hemorrhage of third degree or more occurred in brain ultrasound examination
- Are using sedative medication
- Premature infants use endotracheal tube respirator or high-frequency respirator
- Preterm infants requiring immediate surgical treatment at birth
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
experimental group
control group
Arm Description
maternal voice
no maternal voice
Outcomes
Primary Outcome Measures
heart rate
observation at 7th and 14th day after intervention period
respiratory rate
observation at 7th and 14th day after intervention period
SpO2 concentration
observation at 7th and 14th day after intervention period
behavioral status with crying states of premature infants
observation at 7th and 14th day after intervention period
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05543005
Brief Title
Efficacy Study of an Audio Device Outside Incubator Allowing Broadcasting Maternal Voice on Stability in Preterm Infants
Official Title
Efficacy Study of an Audio Device Outside Incubator Allowing Broadcasting Maternal Voice on Stability in Preterm Infants
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 1, 2022 (Anticipated)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
July 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Chia-Jung Lin
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The study aims to evaluate the impact on the preterm infants' short-term physiological, neurodevelopmental states by employing maternal voice intervention in NICU routine care. This study also evaluates the correlation between effective intervention and maternal depression by employing Edinburgh Postnatal Depression Scale .
Detailed Description
The study designs a two-arm, double blind randomized control trial (RCT) experiment in terms of a block randomization for allocating participants in experimental and control groups respectively. In the experimental group maternal voice in terms of lullaby, music, and meaningful words plays near the head of premature infant in the incubator by 30 mins each time, and totally three times a day over a 14-days intervention duration. Meanwhile a standard care treats premature infants in the control group. A IntelliVue physiological monitor and a behavior scale collects ECG, respiratory rate, SpO2 concentration, and sleep/awake states of premature infants in both groups. Finally, ANOVA analyzes the statistical significance between the measurer and items.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Premature Infant
Keywords
premature infant
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study designs a two-arm, double blind randomized control trial (RCT) experiment in terms of a block randomization for allocating participants in experimental and control groups respectively. In the experimental group maternal voice in terms of lullaby, music, and meaningful words plays near the head of premature infant in the incubator by 30 mins each time, and totally three times a day over a 14-days intervention duration. Meanwhile a standard care treats premature infants in the control group.
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
80 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
experimental group
Arm Type
Experimental
Arm Description
maternal voice
Arm Title
control group
Arm Type
No Intervention
Arm Description
no maternal voice
Intervention Type
Other
Intervention Name(s)
maternal voice intervention
Intervention Description
maternal voice in terms of lullaby, music, and meaningful words plays near the head of premature infant in the incubator by 30 mins each time after routine care period
Primary Outcome Measure Information:
Title
heart rate
Description
observation at 7th and 14th day after intervention period
Time Frame
14th day
Title
respiratory rate
Description
observation at 7th and 14th day after intervention period
Time Frame
14th day
Title
SpO2 concentration
Description
observation at 7th and 14th day after intervention period
Time Frame
14th day
Title
behavioral status with crying states of premature infants
Description
observation at 7th and 14th day after intervention period
Time Frame
14th day
10. Eligibility
Sex
All
Minimum Age & Unit of Time
28 Weeks
Maximum Age & Unit of Time
36 Weeks
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Preterm infants at 28-36 gestational age
Within 10 days in NICU after delivery
Exclusion Criteria:
Has a known chromosomal or congenital abnormality
Major congenital infection
Brain lesions diagnosed prenatally, or neonatal asphyxia at birth.
Toxic use by the mother during pregnancy
Intraventricular hemorrhage of third degree or more occurred in brain ultrasound examination
Are using sedative medication
Premature infants use endotracheal tube respirator or high-frequency respirator
Preterm infants requiring immediate surgical treatment at birth
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chia Jung LIN, master
Phone
+886-928185501
Email
chiajung12@gmail.com
12. IPD Sharing Statement
Learn more about this trial
Efficacy Study of an Audio Device Outside Incubator Allowing Broadcasting Maternal Voice on Stability in Preterm Infants
We'll reach out to this number within 24 hrs